iShares US Healthcare E.T.F. (IYH) Buy, Sell…

Home

Daily Stock Opinions and Ratings

iShares US Healthcare E.T.F. (IYH)

67.93

+0.29 (0.43%)

as of Jun 29, 2026, 8:00:00 pm Market Open.

21 watching

Investor Insights

Jun 29, 2026, 12:00 am

This summary was created by AI, based on 1 opinions in the last 12 months.

The iShares US Healthcare ETF (IYH-N) is experiencing positive sentiment among experts, particularly regarding improvements in Medical Loss Ratio (MLR) expectations for managed-care companies. This improvement signals a potential stabilization and growth within the managed-care sector, which could lead to enhanced profitability. Additionally, there is a promising outlook on Medicare Advantage, providing further clarity that may drive interest and investment in this area. Experts believe these factors can contribute positively to the overall performance of the healthcare sector, making IYH an attractive option for investors looking into healthcare-related funds. Overall, the reviews suggest a cautious optimism around the future trajectory of IYH, highlighting the potential benefits stemming from changes in healthcare policy and financial metrics for managed-care providers.

Consensus

Positive

Valuation

Fair Value

Similar

XLV

COMMENT

Healthcare tends to be a little less correlated to the equity market, so it is an ideal place to be. We are approaching the seasonal strength for biotech at the end of June. The chart on this is showing higher lows and higher highs. A similar one, but hedged to the Cdn$, would be BMO Equal Weight US Healthcare (ZUH-T). (See Top Picks.)

BUY

Owns all the large US healthcare names. Continues to move along at a very nice clip.

BUY

This has big holdings in things like Johnson & Johnson (JNJ-N), Pfizer (PFE-N), Merck (MRK-N), etc. Has done very well year to date.

BUY ON WEAKNESS

Likes this area. Going forward, it will be a defensive space. Broke out past its previous resistance point. If you own, Hold. You could add to that on pullbacks.

BUY

Have liked the sector for quite awhile. Has outperformed the S & P 500 since the beginning of the year. Very heavily weighted to large pharma. Short term there's a little bit of a risk, but long term, it's a place you want to have exposure to.

Showing 16 to 20 of 20 entries

Most Recent Experts

Joe Terranova

Virtus Investment Partners

Stephanie Link, Chief investment strategist, Hightower

Hightower

Jenny Harrington, CEO, Gilman Hill Asset Management

Gilman Hill Asset Management

Jim Lebenthal

Cerity Partners

Larry Berman CFA, CMT, CTA

ETF Capital Management Inc.

Wealthica The ultimate 360° Tracker Your financial life in one place, automatically

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at : [email protected].

iShares US Healthcare E.T.F. (IYH)